Beste Umfassende Diagnose von Lymphomen Hämatologe-Onkologen in der Türkei - TOP -25 Ärzte

Mustafa Solak, MD, ist ein Arzt, der seinen Abschluss an der Medizinischen Fakultät der Hacettepe-Universität gemacht hat und Aufenthalte am Lehr- und Forschungskrankenhaus Istanbul Sisli Etfal und ein Stipendium am Krebsinstitut der Hacettepe-Universität absolviert hat. Er ist spezialisiert auf Brustkrebs, Hodenkrebs, Eierstockkrebs, Lungenkrebs, Kopf-Hals-Krebs und Magen-Darm-Krebs. Er hat auch am MD Anderson Cancer Center der University of Texas, dem Corum Training Hospital der Hitit University und dem Medical Park Hospital gearbeitet.

Education and Career

2011 – 2015, (Internal Medicine Specialist) Istanbul University Istanbul School of Education and Career

Medicine Department of Internal Medicine

2015 – 2016, (Internal Medicine) Specialist Istanbul Haydarpasa Numune Training and Research Hospital

2016 – 2019, (Medical Oncology) Istanbul University Istanbul School of Medicine Department of Medical Oncology

2019 – 2021, (Medical Oncology Specialist) - Istanbul Haydarpasa Numune Training and Research Hospital

2021 – 2024, (Associate Professor) Marmara University School of Medicine Department of Medical Oncology

Memberships in Scientific Organizations

ASCO

ESMO

TTOD 

AVOD 

Publications

In the field of oncology, he has published over 30 peer-reviewed articles at both international and national levels.

Awards Received

EAACI The European Academy of Allergy and Clinical Immunology 2019 Best Poster Award

"The top 3rd verbal presentation, IGICC (11th International Gastrointestinal Cancers Conference – IGICC2021)"

Speeches Delivered at National Congresses, Conferences, and Symposia:

Courses, Meetings, and Certificates

ESMO certified Medical Oncologist since 2019

Assoc. Prof. Ali Eser received his medical education at Uludağ University Faculty of Medicine; He completed his internal medicine residency training at Istanbul Training and Research Hospital and his hematology residency training at Marmara University.

Afterward, he completed his compulsory service at Marmara University Hematology Clinic, firstly at Çanakkale University and then at Bezmialem Vakıf University. He served as a lecturer. After working as a hematology specialist and assistant physician in charge of the adult bone marrow transplant unit for 2 years at Hisar Intercontinental Hospital, he worked as a lecturer at Bezmialem Vakıf University and in the adult bone marrow transplant unit at Istanbul Yeniyüzyıl University, and finally for 1 year. He worked as the responsible physician of the adult bone marrow transplant unit at Liv Hospital Gaziantep Hospital for some time. He received the title of associate professor in March 2022.

Dr. Toluy Özgümüş has graduated from Istanbul University, Cerrahpaşa Faculty of Medicine in 2008 and completed his internal medicine specialty training at Haydarpaşa Numune Training and Research Hospital between 2009 and 2013. He received his Hematology subspecialty training at Marmara University Hematology Department between 2014-2017; He performed his compulsory service at Kars Harakani State Hospital between 2017-2019. He worked at Sancaktepe Şehit Prof. Dr. Ilhan Varak Training and Research Hospital between 2019-2023.

He is experienced in the field of bleeding and coagulation disorders, especially coagulation disorders (thrombophilia), and has dealt with the diagnosis and treatment of more than 1000 patients. Since he worked in the pandemic hospital of the Anatolian side of Istanbul during the pandemic period, he has extensive experience in the hematological findings of Covid-19 infection and the management of Covid-19 infection in hematological diseases. Hundreds of patient experiences are available in the diagnosis of myeloproliferative diseases such as Polycythemia Vera and Essential Thrombocytosis, in their differentiation from blood cell elevations due to other frequently confused causes, and in their treatment. He has experience in the diagnosis and all treatment processes of rare hematological cancers such as multiple myeloma, acute and chronic leukemias, lymphomas and histiocytosis, as well as bone marrow transplantation.

MEDICAL INTERESTS 

Clotting Disorders (Thrombophilia)

Bleeding Disorders

Myeloproliferative Diseases

Anemias (Anemia)

Acute and Chronic Leukemias

lymphomas

Bone marrow transplantation

Education

• Ege Faculty of Medicine 1978
• Specialization in Pediatrics 1982
• Subspecialty Pediatric Oncology 2002 (EU Faculty of Medicine)
• Pediatric Hematology and Oncology 2012 (EU Faculty of Medicine)
• Deputy Chief of Clinic 1988 Tepecik EAH
• Clinical Chief 1993 Tepecik EAH
• Associate Professorship 1995
• Professorship  2002
• Ege U. Faculty of Medicine, faculty member 1998 – 2022
• EU Faculty of Medicine Department of Pediatrics 2009-2018
• Member of Tepecik Education Planning and Coordination Board (1993-1998)
• SSI Tepecik Hospital Ethics Committee Chairman (1996-1998)
• Turkish Society of Pediatric Hematology "Bone Marrow Transplantation Working Group Co-Chair" (2002-2006)
• Turkish Society of Pediatric Hematology "Bone Marrow Transplantation Working Group" (2006-2008)
• Turkish Society of Pediatric Hematology - Responsible for Bone Marrow Transplantation "Online" Data Registry System 2007-ongoing.
• Ege University Regenerative Medicine and Stem Cell Commission Chairman, 2011-2021

Institutional Memberships

• Turkish Medical Association İzmir and Kocaeli Branch
• Turkish National Pediatric Association - İzmir
• European Group for Bone Marrow Transplantation (EBMT); Ege University Pediatric Bone Marrow Transplantation Unit was accredited by the European Group for Bone Marrow Transplantation (EBMT) in June 2007.
• Turkish Society of Pediatric Hematology - Board Member for two terms (2005-2009)
• Turkish Society of Hematology - Board Member for two terms (2001/2005)
• Turkish Pediatric Oncology Association
• Bone Marrow Transplantation Foundation (KITVAK) Member of the Board of Trustees

Units he is the founder of                        

1- SSI Tepecik Hospital Pediatric Oncology Clinic (1990) 
2- SSI Tepecik Hospital Pediatric Bone Marrow Transplantation Unit (1992) 
3- EU Faculty of Medicine Pediatric Bone Marrow Transplantation Unit (1998) 
4- FOUNDER of JOURNAL OF PEDIATRIC RESEARCH, 2014; SCI application was made in 2022.  

Transplantation units that he contributed to the establishment of                        

1. İzmir BUÇH EAH Pediatric Bone Marrow Transplantation Unit (2019) 
2. Ümraniye EAH Pediatric Bone Marrow Transplantation Unit (2020) 
3. Kanuni Sultan Süleyman EAH Pediatric Bone Marrow Transplantation Unit (2020) (Transferred to Çam Sakura EAH)

Awards

• Thrombotic parameters in bone marrow stem cell transplant patients, Pediatric Hematology Congress, Trabzon 2003
• CD133 Antigen in Stem Cell: Pediatric Hematology Congress 2005. Research award
• The role of Toll like receptors in febrile neutropenic patients, Best poster award. Turkish Hematology Congress 2008, Çeşme-İzmir
• National pediatric stem cell transplantation activity- Oral presentation second prize, Turkish Hematology Society Stem Cell Transplantation Congress, 2022, Antalya

Publications

Kansoy S. "Bone Marrow and Stem Cell Transplantation Child Health and Diseases, 1st edition, EU Faculty of Medicine Printing House, 1999, İzmir

Kansoy S. Bone marrow transplantation in Thalassemia Major III. Aegean Thalassemia Days Book, 2000, Izmir

Kansoy S. Pediatric KIT Center Standards in Turkey. Childhood Acute Leukemias, Antalya 2000: 73-5

Kansoy S. Late Side Effects in Children. Special issue of Bone Marrow Transplantation Journal of Turkish Clinics. 2003

Kansoy S. Stem Cell Applications in Bone Marrow and Stem Cell Transplantation. Pediatric Oncology Nursing Course Book, İzmir, 2005

Kansoy S. Cord Blood as a Stem Cell Source. Stem Cell Special Issue. Turkey Clinics, 2008

Kansoy S. Stem Cell Transplantation in Lymphomas. General Pediatrics Book, Ed. Prof.Dr.Enver Hasanoglu, 2009

Kansoy S, Aksoylar S. Bone Marrow Transplantation in Children. Pediatrics, 2014 and 2017

Kansoy S. Rhabdomyosarcoma. Pediatrics, 2014 and 2017

Kansoy S. Approach to the child with cancer according to clinical findings. Pediatrics, 2014 and 2017 

11. Çetingül N, S.Kansoy, M.Kantar. Oncological Diseases. Pediatrics (Ed. A. Cura), 641-672, Ege University Print house, İzmir, 1999.  (1.05 points)

Kansoy S, M.Kantar. Head, Face and Eye Examination. Pediatric Prosthetic Physical Examination and Symptom Information (Ed. A.Cura)

Kantar M. Metabolic Emergency Problems in Oncology. Oncologic Emergencies and Supportive Care in Childhood (Ed. N. Çetingül, S. Kansoy), 15-24, Meta Basım, İzmir, 2003. 

Cord Blood Transplants in Turkey. HEMATOLOGIST, 2016

Kansoy S. Central Nervous System Tumors in Children Pediatrics, 2014 and 2017

Acute myeloblastic leukemia in children and its treatment. Pediatric Oncology Textbook, Poplack's Turkish, 2020

National pediatric stem cell transplant activity, 2020

Childhood stem cell transplantation indications, Turkey Clinics - International book 2020

In addition to the studies and papers in international journals published in large numbers, he is involved in international multicenter studies in some journals with high impact value.

Assoc. Prof. Dr. Oğuzhan BABACAN completed his undergraduate, specialty and sub-specialty education at GATA Military Medical Faculty/Ankara. After becoming a specialist in Pediatrics, he worked in the field of Social Pediatrics for two years, where Healthy Baby Monitoring and vaccine follow-up were carried out. Then, she completed her subspecialty training in Pediatric Hematology and Oncology and continued her studies in the field of pediatric blood and cancer diseases. In addition to the treatment of children suffering from leukemia, lymphoma, solid tumors and other blood diseases, she has been working in the Bone Marrow Transplantation (Transplant) Unit for 13 years in Allogeneic (unrelated and intrafamilial), Autologous (from the patient himself) and Haploidentical (partially HLA compatible) hematopoietic stem cell transplantation. In 2018, he received the title of Associate Professor in the field of Pediatric Hematology and Oncology Science/Art.

MEDICAL AREAS OF INTEREST

Healthy baby follow-up and vaccinations

Lymph node enlargement

Pediatric patients with anemia (anemia)

Leukemia

Lymphoma

Bone Marrow Transplant

ITP

Thalassemias

Hemophiliacs

Solid tumors

Hemangioma

Childhood blood disorders

Children with frequent infections

Fever of unknown origin

Malnutrition in children

Professional Experience

Gayrettepe Florence Nigthingale Hospital

Medical Oncology Department

Besiktas/Istanbul/Turkey (ongoing)

Education:

He became Professor (22/April /2016)

Medical Oncology

Attending Phys.in Gastrointestinal Oncology (January 2005 ,2009)

Istanbul University Oncology Institue,

Department of Medical Oncology

Medical Oncology Fellowship (December 2001-December2004)

Istanbul University, Istanbul Medical Faculty

Hemodialysis Traning (May1996-January1997)

Istanbul University ,bCerrahpasa Medical Faculty

Internal Medicine Residency (November 1991-November 1996)

Istanbul University ,bCerrahpasa Medical Faculty

Ege University Medical Faculty (1985-1991)

Professional Experience

February 1999-November 2001

Metropolitan Florence Nigthingale Hospital

American Cancer Center, Gayrettepe/İstanbul

April1997- October 1998

Bayraktar Dialysis Center

Güngören/ Istanbul

Membership

Turkish Medical Oncology Association

ENET(European Neuroendocrine Tumour Society)

ESMO

ASCO

Undergraduate and Doctoral Education:

* 1992-1999 Ondokuz Mayıs University Faculty of Medicine

* 2002-2007 Inonu University, Faculty of Medicine, Child Health and Diseases,

Pediatrics Residency

* 2015-2018 Inonu University, Faculty of Medicine, Pediatrics, Pediatric

Hematology and Oncology Subspecialization

*2017-Ankara University, Pediatrics, Oncology minor residency (8 months)

Education

• 1986-1989, Bursa High School, Bursa, Turkey
• 1989-1995, Istanbul University, Istanbul School of Medicine, Turkey
• 1999-2003, (Residency) Kadir Has University, School of Medicine, Department of Radiation Oncology, Istanbul, Turkey
• 2015, (Associate Professor) Demiroglu Bilim University, Department of Radiation Oncology, Istanbul, Turkey
• 2021, (Professor) Demiroglu Bilim University, Department of Radiation Oncology, Istanbul, Turkey
• 2024, Istanbul Medipol University, Department of Radiation Oncology, Istanbul, Turkey

Experience

• 1995-1999, Şişli Florence Nightingale Hospital, Istanbul, Cardiology Department
• 2003, Gayrettepe Florence Nightingale Hospital, Istanbul, Department of Radiation Oncology
• 2015, (Associate Professor in Radiation Oncology) Demiroglu Bilim University, Department of Radiation Oncology, Istanbul, Turkey
• 2021, (Professor in Radiation Oncology) Demiroglu Bilim University, Department of Radiation Oncology, Istanbul, Turkey
• 2024, Istanbul Medipol University, Department of Radiation Oncology, Istanbul, Turkey

Prof. Dr. Osman İLHAN graduated from Ankara University Faculty of Medicine in 1978. After completing his internal medicine residency at the same faculty in 1982, he served as a senior resident at the GATA Hematology Clinic during his military service. After completing his mandatory service at SSK Ulus Hospital, he returned to Ankara University Faculty of Medicine for a subspecialty. In 1990, he became an associate professor of hematology. He worked in Genoa, Italy to increase his knowledge and experience in leukemia. He was part of the team that performed the first bone marrow stem cell transplant in Turkey. In 1996, he went to the MD Anderson Cancer Center in the USA to work on "Stem Cell Mobilization, Cryopreservation, and Transplantation." In 1996, he became a professor of hematology. In 1999, he was elected as the regional president of ESFH (European Society for Hemapheresis). Dr. İlhan, who was the founder and president of the Hemapheresis Society in 2000, joined the World Apheresis Association (WAA) in 2001. He became the President of the Turkish Hematology Association in October 2001. Dr. İlhan, who is an active member of the European Hematology Association (EHA), was a member of the accreditation committee (ECAH) for education. He played a role in the accreditation of Turkish hematologists in CME credits by participating in the accreditation of congresses and courses held in Turkey as a Provider Status. He served as the founding president of the Cellular Therapy and Regenerative Medicine Association established in 2008. He became the founding president of the Geriatric Hematology Association in 2011. He is the Honorary President of the World Apheresis Congress (WAA) held in 2012. Dr. İlhan, who previously served on drug licensing and ethics committees at the Ministry of Health, has also served as the Chairman of the Photopheresis-Apheresis Commission and the Scientific Committee for Bone Marrow Transplantation, as well as the Chairman of the National Organ Tissue Cell Coordination Board, the Scientific Board of Cord Blood, and the Stem Cell Research Board. He is the founding president of the STEM CELL FOUNDATION and has played an important role in the establishment of TURKOK (Turkish Stem Cell Donor Bank). Dr. İlhan has over 300 publications in journals registered in PubMed and more than 5000 citations. He holds the Platinum CME certificate from the European Hematology Association. He owns four brands/patents named “Kökten Çözüm (Deep Solution), Telehematoloji (Telehematology), Hemaferez (Hemapheresis), Kanser Kök Hücresi (Cancer Stem Cell)”. He is currently the President of the Ankara Medical Association. Prof. Dr. Osman İlhan, who served at Ankara University Faculty of Medicine for 50 years, began working at Özel Koru Ankara Hospital as of January 1, 2023.

His medical interests include:

Hematopoietic Stem Cell Transplantation (Autologous, Allogeneic)

Acute Leukemia

Chronic Leukemia Treatments

Hodgkin Lymphoma

Non-Hodgkin Lymphoma Treatments

Multiple Myeloma Treatments, MDS

Aplastic Anemia

ITP

TTP Treatments

Hypercoagulability

Hereditary Thrombophilia Treatments

Therapeutic Apheresis

Photopheresis

Geriatric Hematology Diseases.

Dr. hat ein Medizindiplom von der Uludağ University Medical College, Bursa, Türkei (1983), ein Postdoktorandenstipendium in Thermoradiotherapie von der Thomas Jefferson University, Philadelphia, PA (1990-1994) und eine Facharztausbildung in Radiation Oncology vom Center of Oncology & Nuclear Medizin, Istanbul, Türkei (1990). Er hatte auch Positionen als Professor, Vorsitzender und Koordinator für die Akkreditierung der Fakultät am Uludağ University Medical College (1991-2005), Professor und Direktor am Anadolu Medical Center (2004-2017) und Direktor am Ceylan International Hospital und am Medicana Bursa Hospital (2017) inne -gegenwärtig).

Prof. Dr. Serdar Bedii Omay absolvierte 1985 die Hacettepe Medical School und spezialisierte sich später auf Innere Medizin und Hämatologie. Er hat 65 wissenschaftliche Artikel, 112 Konferenzbeiträge und 34 Konferenzpräsentationen auf dem Gebiet der Hämatologie und Knochenmarktransplantation veröffentlicht. 1995 arbeitete er auch als Facharzt für Hämatologie und Arzt für molekulare Hämatologie an der Medizinischen Fakultät Japan Mie.

Prof. Baytan ist ein Arzt, der 1992 seinen Abschluss an der Medizinischen Fakultät der Universität Ankara machte und Facharzt für Medizin an der Medizinischen Fakultät der Universität Uludağ, Abteilung für Kinderkrankheiten, wurde. Er ist erfahren in der Diagnose und Behandlung von Krebs im Kindesalter, Leukämie, Anämie und anderen Krankheiten. Er hat 15 Artikel in internationalen Fachzeitschriften veröffentlicht, 9 Volltexte präsentiert und auf internationalen wissenschaftlichen Tagungen veröffentlicht, 3 Bücher/Buchkapitel geschrieben und 8 Artikel in lokalen Fachzeitschriften veröffentlicht.

Lizenzierter Radioonkologe mit 8 Jahren medizinischer Ausbildung, einschließlich Grundstudium an der Medizinischen Fakultät der Marmara-Universität (2004-2011) und Spezialisierung auf Radioonkologie an der Medizinischen Fakultät der Marmara-Universität (2012-2016). Frühere Ausbildung an der Sixteen Numbered Shirvan School (Aserbaidschan) High School (1998-2004).